Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent RE39419 Estrogen agonist/antagonist metabolites

Patent RE39419 was granted and assigned to Pfizer on December, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 6 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 6 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Chandra A. Prakash0
James F. Eggler0
Kim A. Johnson0
Wesley W. Day0
Edits on 31 Aug, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 31 Aug, 2023
Edits made to:
Article (+469 characters)
Article

Patent abstract

This invention relates to compounds that are mammalian metabolites of (−)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol. The compounds of the invention can be used as standards for analytical assays or as intermediates for the further chemical synthesis or biosynthesis of chemical entities. The invention also relates to pharmaceutical compositions for the treatment of disease and methods of treating disease.

Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=RE0394190
Edits on 18 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent RE039419 Estrogen agonist/antagonist metabolites US Patent RE39419 Estrogen agonist/antagonist metabolites

Infobox
Patent Number
RE0394190
Patent Number
RE394190
Edits on 25 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Pfizer
Pfizer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
RE0394190
Date of Patent
December 5, 2006
0
Patent Application Number
104487510
Date Filed
May 30, 2003
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=RE0394190
Patent Primary Examiner
‌
Fiona T. Powers
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=RE039419
Edits on 19 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent RE039419 Estrogen agonist/antagonist metabolites

Infobox
Is a
Patent
Patent
Current assignee
Pfizer
Pfizer
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
RE039419
Date of patent
December 5, 2006
Patent application number
10448751
Date Filed
May 30, 2003
Patent primary examiner
‌
Fiona T. Powers

Find more entities like US Patent RE39419 Estrogen agonist/antagonist metabolites

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.